Fripp Design
Develops and commercializes Picsima, a patented 3D printing technology for full-color silicone, enabling direct fabrication of soft tissue prosthetics and industrial silicone parts.
- CEO / Founder
- Tom Fripp
- Team Size
- 1-10
- Stage
- Active
- Total Funding
- Undisclosed
- Latest Round
- Grant
- Key Investors
- Innovate UK; Private investors
Technology & Products
Key Products
Picsima 3D printing technology; Product design and prototyping services; First Stage Prototyping (3D rendered images)
Technological Advantage
Proprietary Picsima technology achieves precise polymerization and extrusion of silicone, protected by UK patent (granted 2016), developed with support from Innovate UK grant and private investors.
Differentiation
Value Proposition
Enables direct 3D printing of off-the-shelf two-part curing silicones with full-color capability, reducing production time for custom soft tissue prosthetics from weeks to hours while achieving realistic aesthetics.
How They Differentiate
Unlike Stratasys (PolyJet) or Carbon (Digital Light Synthesis) which use photopolymers, Picsima directly prints off-the-shelf silicone materials, offering superior biocompatibility and elasticity for medical prosthetics without post-processing infiltration.
Market & Competition
Target Customers
Medical device manufacturers, prosthetics clinics, industrial silicone part producers
Industry Verticals
Medical; Consumer; Industrial
Competitors
Open Bionics; UNYQ
Growth & Milestones
Growth Metrics
Announced sale of 3D printing silicone intellectual property, indicating strategic shift or business development activity.
Major Milestones
UK patent granted for Picsima (2016); Innovate UK grant awarded (October 2017); Development of full-color silicone 3D printing for prosthetics
Notable Customers
Apple; Johnson and Johnson; Smith and Nephew; Disney; Jaguar Land Rover